Jane Street Group, LLC Enanta Pharmaceuticals Inc Transaction History

Jane Street Group, LLC

$72.9 Billion
Q1 2024

A detailed history of Jane Street Group, LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 20,918 shares of ENTA stock, worth $271,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,918

Previous 74,440 71.9%

Holding current value

$271,306

Previous $700,000 47.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$10.08 - $17.46 $539,501 - $934,494	-53,522 Reduced 71.9%	20,918 $365,000
Q4 2023 Feb 14, 2024	SELL	$8.18 - $10.78 $569,647 - $750,708	-69,639 Reduced 48.33%	74,440 $700,000
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $1.49 Million - $2.97 Million	134,360 Added 1382.45%	144,079 $1.61 Million
Q2 2023 Aug 14, 2023	SELL	$20.68 - $39.85 $216,457 - $417,109	-10,467 Reduced 51.85%	9,719 $207,000
Q1 2023 May 15, 2023	BUY	$38.82 - $54.59 $783,620 - $1.1 Million	20,186 New	20,186 $816,000

Q1 2022 May 17, 2022	SELL	$56.06 - $74.11 $176,981 - $233,965	-3,157 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$60.19 - $97.37 $355,301 - $574,775	-5,903 Reduced 65.15%	3,157 $236,000
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $396,465 - $481,176	9,060 New	9,060 $399,000
Q1 2021 May 18, 2021	SELL	$41.69 - $54.95 $198,152 - $261,177	-4,753 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$41.16 - $47.47 $41,736 - $48,134	-1,014 Reduced 17.58%	4,753 $200,000
Q3 2020 Nov 17, 2020	BUY	$43.36 - $53.53 $70,763 - $87,360	1,632 Added 39.47%	5,767 $264,000
Q2 2020 Aug 17, 2020	BUY	$46.37 - $57.58 $191,739 - $238,093	4,135 New	4,135 $208,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $194,101 - $299,212	-4,826 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $61,079 - $70,206	-1,054 Reduced 17.93%	4,826 $298,000
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $205,353 - $301,365	3,418 Added 138.83%	5,880 $353,000
Q2 2019 Aug 15, 2019	BUY	$81.3 - $97.35 $200,160 - $239,675	2,462 New	2,462 $208,000
Q1 2019 May 16, 2019	SELL	$69.08 - $105.66 $370,545 - $566,760	-5,364 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$65.41 - $84.65 $350,859 - $454,062	5,364 New	5,364 $380,000

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

21.7M

Call Options Held

9.4K

Put Options Held

3.3K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $269M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Enanta Pharmaceuticals Inc Transaction History